Maintenance fees coming due
GlaxoSmithKline Intellectual Property Development Limited
30 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Nov 21, 2026. Unpaid by May 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,292,987 | Heterocyclic Amides as Kinase Inhibitors In force Fee due Nov 21, 2026 Lapses if unpaid May 21, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Nov 21, 2026 | May 21, 2027 | High confidence | |
| US 11,666,874 | Methods and Apparatus for Variable Emulsification In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 10,328,052 | D-Proline Derivatives as Sap Depleting Agent In force Fee due Dec 25, 2026 Lapses if unpaid Jun 25, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Dec 25, 2026 | Jun 25, 2027 | High confidence | |
| US 10,344,088 | Antigen Binding Proteins In force Fee due Jan 9, 2027 Lapses if unpaid Jul 9, 2027 · Medium confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Jan 9, 2027 | Jul 9, 2027 | Medium confidence | |
| US 11,697,665 | C-Mannoside Compounds Useful for the Treatment of Urinary Tract Infections In force Fee due Jan 11, 2027 Lapses if unpaid Jul 12, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Jan 11, 2027 | Jul 12, 2027 | High confidence | |
| US 10,351,627 | Icos Binding Proteins In force Fee due Jan 16, 2027 Lapses if unpaid Jul 16, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Jan 16, 2027 | Jul 16, 2027 | High confidence | |
| US 10,364,266 | Novel Compounds In force Fee due Jan 30, 2027 Lapses if unpaid Jul 30, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Jan 30, 2027 | Jul 30, 2027 | High confidence | |
| US 10,407,407 | Benzoimidazole Derivatives as PAD4 Inhibitors In force Fee due Mar 10, 2027 Lapses if unpaid Sep 10, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Mar 10, 2027 | Sep 10, 2027 | High confidence | |
| US 10,428,078 | Compounds In force Fee due Apr 1, 2027 Lapses if unpaid Oct 1, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Apr 1, 2027 | Oct 1, 2027 | High confidence | |
| US 11,771,711 | Substituted Pyridines as DNMT1 Inhibitors In force Fee due Apr 3, 2027 Lapses if unpaid Oct 4, 2027 · High confidence | GlaxoSmithKline Intellectual Property Development Limited | In force | Apr 3, 2027 | Oct 4, 2027 | High confidence | |
| 20 more maintenance fees coming due in the 12 months from Nov 18, 2026 · Pro | |||||||
10 of 30 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.